OTC:ADAPY | News — Page 3 | Adaptimmune Therapeutics PLC

ADAPY News — Page 3

Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.

DateTypePublisherHeadlineSummary
2015-12-15Foreign issuer reportSEC filingAdaptimmune Therapeutics PLC filed Form 6-KAdaptimmune Therapeutics PLC filed Form 6-K.
2015-12-03Foreign issuer reportSEC filingAdaptimmune Therapeutics PLC filed Form 6-KAdaptimmune Therapeutics PLC filed Form 6-K.
2015-11-24Foreign issuer reportSEC filingAdaptimmune Therapeutics PLC filed Form 6-KAdaptimmune Therapeutics PLC filed Form 6-K.
2015-11-18Foreign issuer reportSEC filingAdaptimmune Therapeutics PLC filed Form 6-KAdaptimmune Therapeutics PLC filed Form 6-K.
2015-11-13Foreign issuer reportSEC filingAdaptimmune Therapeutics PLC filed Form 6-KAdaptimmune Therapeutics PLC filed Form 6-K.
2015-11-12Foreign issuer reportSEC filingAdaptimmune Therapeutics PLC filed Form 6-KAdaptimmune Therapeutics PLC filed Form 6-K.
2015-11-05Foreign issuer reportSEC filingAdaptimmune Therapeutics PLC filed Form 6-KAdaptimmune Therapeutics PLC filed Form 6-K.
2015-10-22Foreign issuer reportSEC filingAdaptimmune Therapeutics PLC filed Form 6-KAdaptimmune Therapeutics PLC filed Form 6-K.
2015-10-19Foreign issuer reportSEC filingAdaptimmune Therapeutics PLC filed Form 6-KAdaptimmune Therapeutics PLC filed Form 6-K.
2015-10-13Foreign issuer reportSEC filingAdaptimmune Therapeutics PLC filed Form 6-KAdaptimmune Therapeutics PLC filed Form 6-K.
2015-10-09Foreign issuer reportSEC filingAdaptimmune Therapeutics PLC filed Form 6-KAdaptimmune Therapeutics PLC filed Form 6-K.
2015-09-15Foreign issuer reportSEC filingAdaptimmune Therapeutics PLC filed Form 6-KAdaptimmune Therapeutics PLC filed Form 6-K.
2015-09-10Foreign issuer reportSEC filingAdaptimmune Therapeutics PLC filed Form 6-KAdaptimmune Therapeutics PLC filed Form 6-K.
2015-09-02Foreign issuer reportSEC filingAdaptimmune Therapeutics PLC filed Form 6-KAdaptimmune Therapeutics PLC filed Form 6-K.
2015-07-20Foreign issuer reportSEC filingAdaptimmune Therapeutics PLC filed Form 6-KAdaptimmune Therapeutics PLC filed Form 6-K.
2015-07-02Foreign issuer reportSEC filingAdaptimmune Therapeutics PLC filed Form 6-KAdaptimmune Therapeutics PLC filed Form 6-K.
2015-06-01Foreign issuer reportSEC filingAdaptimmune Therapeutics PLC filed Form 6-KAdaptimmune Therapeutics PLC filed Form 6-K.
2015-05-21Foreign issuer reportSEC filingAdaptimmune Therapeutics PLC filed Form 6-KAdaptimmune Therapeutics PLC filed Form 6-K.
2015-05-13Foreign issuer reportSEC filingAdaptimmune Therapeutics PLC filed Form 6-KAdaptimmune Therapeutics PLC filed Form 6-K.